BACKGROUND: We aimed to identify trajectories of inflammation in older adults at elevated risk for syndromal depression and anxiety and to determine whether baseline physical, cognitive, and psychosocial factors could distinguish 15-month longitudinal trajectories. METHODS: Older adults (N = 195, mean age (±SD) = 74.4 years (9.0) participating in three depression and anxiety prevention protocols completed a comprehensive battery of psychosocial assessments and provided blood samples for analysis of interleukin-6 (IL-6) every 3 months over a maximum of 15 months. Group-based trajectory modeling identified trajectories. Adjusted logistic regression examined associations between baseline factors and trajectory groups. RESULTS: Two 15-month trajectories were identified: stable lower IL-6 levels (84%; mean (±SD) = 3.2 (2.1) pg/mL); and consistently higher IL-6 levels (16%; mean = 9.5 (7.4) pg/mL). Poor sleep quality predicted consistently higher levels of IL-6 (OR = 1.9, 95% CI = 1.03-3.55). CONCLUSION: Poor sleep quality may represent a therapeutic target to reduce inflammation.
BACKGROUND: We aimed to identify trajectories of inflammation in older adults at elevated risk for syndromal depression and anxiety and to determine whether baseline physical, cognitive, and psychosocial factors could distinguish 15-month longitudinal trajectories. METHODS: Older adults (N = 195, mean age (±SD) = 74.4 years (9.0) participating in three depression and anxiety prevention protocols completed a comprehensive battery of psychosocial assessments and provided blood samples for analysis of interleukin-6 (IL-6) every 3 months over a maximum of 15 months. Group-based trajectory modeling identified trajectories. Adjusted logistic regression examined associations between baseline factors and trajectory groups. RESULTS: Two 15-month trajectories were identified: stable lower IL-6 levels (84%; mean (±SD) = 3.2 (2.1) pg/mL); and consistently higher IL-6 levels (16%; mean = 9.5 (7.4) pg/mL). Poor sleep quality predicted consistently higher levels of IL-6 (OR = 1.9, 95% CI = 1.03-3.55). CONCLUSION: Poor sleep quality may represent a therapeutic target to reduce inflammation.
Authors: Jordan F Karp; Jun Zhang; Abdus S Wahed; Stewart Anderson; Mary Amanda Dew; G Kelley Fitzgerald; Debra K Weiner; Steve Albert; Ari Gildengers; Meryl Butters; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2019-03-21 Impact factor: 4.105
Authors: Steven M Albert; Jennifer King; Stewart Anderson; Mary Amanda Dew; Jun Zhang; Sarah T Stahl; Jordan F Karp; Ariel G Gildengers; Meryl A Butters; Charles F Reynolds Iii Journal: Am J Geriatr Psychiatry Date: 2019-01-10 Impact factor: 4.105
Authors: Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin Journal: Brain Behav Immun Date: 2009-04-21 Impact factor: 7.217
Authors: Ariel G Gildengers; Meryl A Butters; Steven M Albert; Stewart J Anderson; Mary Amanda Dew; Kirk Erickson; Linda Garand; Jordan F Karp; Michael H Lockovich; Jennifer Morse; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2015-11-18 Impact factor: 4.105
Authors: Brenda W J H Penninx; Stephen B Kritchevsky; Anne B Newman; Barbara J Nicklas; Eleanor M Simonsick; Susan Rubin; Michael Nevitt; Marjolein Visser; Tamara Harris; Marco Pahor Journal: J Am Geriatr Soc Date: 2004-07 Impact factor: 5.562
Authors: Stephen F Smagula; Francis E Lotrich; Howard J Aizenstein; Breno S Diniz; Jeffrey Krystek; Gregory F Wu; Benoit H Mulsant; Meryl A Butters; Charles F Reynolds; Eric J Lenze Journal: Int J Geriatr Psychiatry Date: 2016-06-10 Impact factor: 3.485
Authors: Malcolm P Forbes; Adrienne O'Neil; Melissa Lane; Bruno Agustini; Nick Myles; Michael Berk Journal: Drugs Aging Date: 2021-04-29 Impact factor: 3.923